Coverage of IDWeek 2016
- Details
- Category: HIV Treatment
- Published on Friday, 04 November 2016 00:00
- Written by HIVandHepatitis.com
HIVandHepatitis.com coverage of IDWeek 2016, held October 26-30 in New Orleans.
Conference highlights include experimental HIV therapies, PrEP and other biomedical HIV prevention, antibiotic resistance, and emerging infectious diseases such as Ebola virus and Zika virus.
Full listing of coverage by topic
11/4/16
New Research Sheds Light on Origin of HIV in U.S., Dispelling Patient Zero Myth
- Details
- Category: HIV Prevention
- Published on Wednesday, 02 November 2016 00:00
- Written by Liz Highleyman
A new genetic analysis shows that HIV likely spread from the Caribbean to New York City around 1971 and from there to San Francisco around 1976, laying to rest the misconception that a Canadian flight attendant, Gaetan Dugas, was responsible for sparking the epidemic in the United States.
HIV Glasgow: Tests of Online PrEP Purchases Find No Fakes and Adequate Drug Levels
- Details
- Category: Pre-exposure Prophylaxis (PrEP)
- Published on Tuesday, 01 November 2016 00:00
- Written by Gus Cairns
A sexual health clinic in central London that offered to test drug levels in users of tenofovir/emtricitabine pre-exposure prophylaxis (PrEP) who had bought it online found adequate levels of both drugs in their blood, and no sample suggesting counterfeit drugs.
IDWeek 2016: HIV+ Men and Men on PrEP in Boston See Large Increase in Sexually Transmitted Infections
- Details
- Category: Pre-exposure Prophylaxis (PrEP)
- Published on Tuesday, 01 November 2016 00:00
- Written by Liz Highleyman
Rates of gonorrhea, syphilis, and chlamydia have risen steeply at Fenway Health in Boston since 2011, according to presentation last week at IDWeek in New Orleans. Being HIV-positive and using pre-exposure prophylaxis (PrEP) to prevent HIV were associated with higher risk of getting-sexually transmitted infections (STIs), but more frequent STI testing and treatment could potentially help reduce the numbers.
HIVR4P: New HIV Prevention Tools Will Need Marketing and Effective Health Services to Expand Reach
- Details
- Category: HIV Prevention
- Published on Tuesday, 01 November 2016 00:00
- Written by Roger Pebody
There is a naivety among many HIV prevention researchers and advocates about the steps needed to introduce and implement new HIV prevention technologies such as oral pre-exposure prophylaxis (PrEP), vaginal rings, and vaccines, according to speakers at the HIV Research for Prevention (HIVR4P 2016) conference in Chicago last month. Developing an effective prevention method is the easy part, they suggested -- ensuring that the product reaches end users who need them can be more challenging.
More Articles...
- IDWeek 2016: Do HIV-Positive Men with Undetectable Viral Load Need to Wear Condoms?
- IDWeek 2016: Electronic Health Records Can Help Select Candidates for HIV PrEP
- HIVR4P 2016: Some Americans Who Need PrEP the Most Face the Greatest Barriers
- HIVR4P 2016: PrEP Knowledge and Use Increases in San Francisco, 12,500 People Now on PrEP